Home > Healthcare > Medical Devices > Implantable Devices > Iliac Stents Market

Iliac Stents Market Share

Report ID: GMI8576
Published Date: Mar 2024
Report Format: PDF

Download Free Sample

Iliac Stents Market Share

The iliac stents industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products based on different technologies is among a key market strategy.

Iliac Stents Market Companies

Some of the eminent market participants operating in the iliac stents industry include:

Abbott Laboratories
Alvimedica
Becton, Dickinson and Company
Biotronik
Boston Scientific Corporation
B. Braun SE
Cook
Getinge AB
iVascular
Medtronic Plc

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Iliac stents market size was USD 899.9 million in 2023 and is expected to register 5% CAGR from 2024-2032 owing to the increasing prevalence of peripheral artery disease (PAD) worldwide.

The balloon-expandable iliac segment and is expected to register 5.2% CAGR from 2024-2032 due to their familiarity with the deployment technique and perceived ease of use compared to other type of stents.

North America iliac stents industry reached USD 216.8 million in 2023 and is expected to register a commendable CAGR from 2024-2032 due to increasing awareness among patients and healthcare providers about vascular diseases and available treatment options in the region.

Abbott Laboratories, Alvimedica, Becton, Dickinson and Company, Biotronik, Boston Scientific Corporation, B. Braun SE, Cook, Getinge AB, iVascular, and Medtronic Plc, are some of the major iliac stents companies worldwide.